MétaCan
Menu
Back to cohort
Record W3184613988 · doi:10.1093/jnci/djab147

Breast and Prostate Cancer Risks for Male<i>BRCA1</i>and<i>BRCA2</i>Pathogenic Variant Carriers Using Polygenic Risk Scores

2021· article· en· W3184613988 on OpenAlexafffund
Daniel R. Barnes, Valentina Silvestri, Goska Leslie, Lesley McGuffog, Joe Dennis, Xin Yang, Julian Adlard, Bjarni A. Agnarsson, Munaza Ahmed, Kristiina Aittomäki, Irene L. Andrulis, Aðalgeir Arason, Norbert Arnold, Bernd Auber, Jacopo Azzollini, Judith Balmañà, Rósa B. Barkardóttir, Daniel Barrowdale, Julian Barwell, Muriel Belotti, Javier Benı́tez, Pascaline Berthet, Susanne E. Boonen, Åke Borg, Anikó Bozsik, Angela F. Brady, Paul Brennan, Carole Brewer, Joan Brunet, Agostino Bucalo, Saundra S. Buys, Trinidad Caldés, Maria A. Caligo, Ian Campbell, Hayley Cassingham, Lise Lotte Christensen, Giulia Cini, Kathleen Claes, Jackie Cook, Anna Coppa, Laura Cortesi, Giuseppe Damante, Esther Darder, Rosemarie Davidson, Miguel de la Hoya, Kim De Leeneer, Robin De Putter, Jesús Del Valle, Orland Dı́ez, Yuan Chun Ding, Susan M. Domchek, Alan Donaldson, Jacqueline Eason, Rosalind A. Eeles, Christoph Engel, D. Gareth Evans, Lídia Feliubadaló, Florentia Fostira, Megan N. Frone, Debra Frost, David Gallagher, Andrea Gehrig, Sophie Giraud, Gord Glendon, Andrew K. Godwin, David E. Goldgar, Mark H. Greene, Helen Gregory, Eva Groß, Eric Hahnen, Ute Hamann, Thomas van Overeem Hansen, Helen Hanson, Julia Hentschel, Judit Horváth, Louise Izatt, Á. Izquierdo, Paul A. James, Ramūnas Janavičius, Uffe Birk Jensen, Oskar T. Johannsson, Esther M. John, Gero Kramer, Lone Kroeldrup, Torben A. Kruse, Charlotte Kvist Lautrup, Conxi Lázaro, Fabienne Lesueur, Adrià López‐Fernández, Siranoush Manoukian, Zoltán Mátrai, Laura Matricardi, Kara N. Maxwell, Noura Mebirouk, Alfons Meindl, Marco Montagna, Álvaro N.A. Monteiro, Patrick J. Morrison, Taru Muranen, Alex Murray, Katherine L. Nathanson, Susan L. Neuhausen, Heli Nevanlinna, Tú Nguyen‐Dumont, Dieter Niederacher, Edith Oláh, Olufunmilayo I. Olopade, Domenico Palli, Michael T. Parsons, Inge Søkilde Pedersen, Bernard Peissel, Pedro Pérez‐Segura, Paolo Peterlongo, Annabeth Høgh Petersen, Pedro Pinto, Mary Porteous, Caroline Pottinger, Miquel Angel Pujana, Paolo Radice, Juliane Ramser, Johanna Rantala, Mark E. Robson, Mark T. Rogers, Karina Rønlund, Andreas Rump, A.M. SÁnchez De Abajo, Payal D. Shah, Saba Sharif, Lucy Side, Christian F. Singer, Zsofia Stadler, Linda Steele, Dominique Stoppa‐Lyonnet, Christian Sutter, Yen Y. Tan, Manuel R. Teixeira, Àlex Teulé, Darcy L. Thull, Marc Tischkowitz, Amanda E. Toland, Stefania Tommasi, Angela Toss, Alison H. Trainer, Vishakha Tripathi, Virginia Valentini, Christi J. van Asperen, Marta Venturelli, Alessandra Viel, Joseph Vijai, Lisa Walker, Shan Wang‐Gohrke, Barbara Wappenschmidt, Anna Whaite, Ines Zanna, Kenneth Offit, Mads Thomassen, Fergus J. Couch, Rita K. Schmutzler, Jacques Simard, Douglas F. Easton, Georgia Chenevix‐Trench, Antonis C. Antoniou, Laura Ottini

Bibliographic record

VenueJNCI Journal of the National Cancer Institute · 2021
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsUniversité LavalMcGill UniversityCentre hospitalier universitaire de QuébecMount Sinai HospitalLunenfeld-Tanenbaum Research InstituteUniversity of Toronto
FundersJonsson Comprehensive Cancer CenterNational Center for Advancing Translational SciencesNational Cancer InstituteMedical Research CouncilCanadian Institutes of Health ResearchUniversity of California, Los AngelesNational Institutes of HealthKerry Group Kuok FoundationFreistaat SachsenCentro de Investigación Biomédica en Red de CáncerFox Chase Cancer CenterMinistero dello Sviluppo EconomicoHospices Civils de LyonDeutsche KrebshilfeAssociazione Italiana per la Ricerca sul CancroEuropean Regional Development FundCentre National de la Recherche ScientifiqueLietuvos Mokslo TarybaUniversity of California, San FranciscoUniversiteit GentOvarian Cancer Research FundMinisterio de Economía y CompetitividadLandspítali HáskólasjúkrahúsHungarian Scientific Research FundKorea Health Industry Development InstituteKWF KankerbestrijdingUniversitair Ziekenhuis GentNederlandse Organisatie voor Wetenschappelijk OnderzoekInstitut National de la Santé et de la Recherche MédicaleMinistero della SaluteGeneralitat de CatalunyaRussian Foundation for Basic ResearchCancer Association of South AfricaMinisterstvo Školství, Mládeže a TělovýchovyNational Breast Cancer FoundationEuropean CommissionNemzeti Kutatási Fejlesztési és Innovációs HivatalNational Institute for Health and Care ResearchCancer Research UKGovernment of CanadaMinistero dell’Istruzione, dell’Università e della RicercaNRG OncologyMemorial Sloan-Kettering Cancer CenterFondation du cancer du sein du QuébecCedars-Sinai Medical CenterIsrael Cancer AssociationInstitut Gustave-RoussyUniversity of PennsylvaniaFundación Mutua MadrileñaMinistère du Développement Économique, de l’Innovation et de l’ExportationBreast Cancer Research FoundationUniverzita Karlova v PrazeMcGill UniversityNational Institute of General Medical SciencesInstitut National Du CancerDipartimenti di EccellenzaGenome CanadaUnicancerClalit Health ServicesDeutsches KrebsforschungszentrumKræftens BekæmpelseNIH Office of the DirectorMinistério da Ciência, Tecnologia e InovaçãoKansas Bioscience AuthorityDr. Ralph and Marian Falk Medical Research TrustSusan G. Komen for the CureGeorgetown UniversityFonds Wetenschappelijk OnderzoekCancer Center, University of KansasCancerfondenCancer AustraliaNational Health and Medical Research CouncilJewish General HospitalFisher Center for Alzheimer's Research FoundationInstituto de Salud Carlos IIIOhio State UniversityBeth Israel Deaconess Medical CenterIstituto Oncologico VenetoRoyal Marsden NHS Foundation TrustEuropean Social FundUniversity of Chicago
KeywordsOncologyMedicineProstate cancerBreast cancerLifetime riskInternal medicineProstatePolygenic risk scoreCancerGynecologyBiologyGeneticsGeneGenotype

Abstract

fetched live from OpenAlex

BACKGROUND: Recent population-based female breast cancer and prostate cancer polygenic risk scores (PRS) have been developed. We assessed the associations of these PRS with breast and prostate cancer risks for male BRCA1 and BRCA2 pathogenic variant carriers. METHODS: 483 BRCA1 and 1318 BRCA2 European ancestry male carriers were available from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). A 147-single nucleotide polymorphism (SNP) prostate cancer PRS (PRSPC) and a 313-SNP breast cancer PRS were evaluated. There were 3 versions of the breast cancer PRS, optimized to predict overall (PRSBC), estrogen receptor (ER)-negative (PRSER-), or ER-positive (PRSER+) breast cancer risk. RESULTS: PRSER+ yielded the strongest association with breast cancer risk. The odds ratios (ORs) per PRSER+ standard deviation estimates were 1.40 (95% confidence interval [CI] =1.07 to 1.83) for BRCA1 and 1.33 (95% CI = 1.16 to 1.52) for BRCA2 carriers. PRSPC was associated with prostate cancer risk for BRCA1 (OR = 1.73, 95% CI = 1.28 to 2.33) and BRCA2 (OR = 1.60, 95% CI = 1.34 to 1.91) carriers. The estimated breast cancer odds ratios were larger after adjusting for female relative breast cancer family history. By age 85 years, for BRCA2 carriers, the breast cancer risk varied from 7.7% to 18.4% and prostate cancer risk from 34.1% to 87.6% between the 5th and 95th percentiles of the PRS distributions. CONCLUSIONS: Population-based prostate and female breast cancer PRS are associated with a wide range of absolute breast and prostate cancer risks for male BRCA1 and BRCA2 carriers. These findings warrant further investigation aimed at providing personalized cancer risks for male carriers and informing clinical management.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.036
GPT teacher head0.332
Teacher spread0.295 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations42
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueJNCI Journal of the National Cancer InstituteSame topicBRCA gene mutations in cancerFrench-language works237,207